Long-term follow-up of newborns with low Apgar scores
Official title: Establishment of a Longitudinal Cohort for Newborns With Low Apgar Scores at Birth
Run by Peking University Third Hospital · NCT06961123 · Data updated 2026-11-12
This study is trying to find ways to help newborns with low Apgar scores by looking at their care and outcomes over time.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Peking University Third Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | March 11, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | May 7, 2025 |
| Trial ID | NCT06961123 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are newborns born at Peking University Third Hospital with Apgar scores of 7 or lower.
✕Probably not a fit
Patients with serious congenital malformations affecting development or whose families refuse participation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to establish a cohort of newborns with low Apgar scores to identify risk factors and implement interventions to improve outcomes. It includes both retrospective and prospective components, analyzing data from newborns born at Peking University Third Hospital with Apgar scores of 7 or lower. The study will evaluate neonatal resuscitation procedures and provide ongoing management and intervention guidance to enhance long-term prognosis for these infants.
Why it matters
Potential benefit: If successful, this study could lead to improved clinical care and outcomes for newborns with low Apgar scores.
How similar studies have gone: Other studies have shown success in improving outcomes for newborns with low Apgar scores through targeted interventions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Retrospective cohort inclusion criteria: Newborns born between January 1, 2006 and before the start of the project at Peking University Third Hospital with Apgar scores ≤ 7 at 1 minute, 5 minutes, or 10 minutes. Prospective cohort inclusion criteria: Newborns born at Peking University Third Hospital between the start of the project and December 31, 2027, with an Apgar score of ≤ 7 at 1 minute, 5 minutes, or 10 minutes. Exclusion Criteria: * There are serious congenital malformations that affect physical and neurological development, and family members refuse to participate in the study
Where it's running
-
Peking University Third Hospital
Beijing, China Recruiting
Study contacts
- Study coordinator: qingqing wang
- Email: wangqing01s@163.com
- Phone: 86+15101020751
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.